Search research articles
Contact Us
Filters
Showing results (81-90 of 638) with videos related to
Page
of 64
Sort By:
Annual Review of Physiology
|
December 16, 2015
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
Joel T Haas, Sven Francque, Bart Staels
Frontiers in Bioscience : a Journal and Virtual Library
|
May 9, 2007
Genetically-engineered animals as research models for atherosclerosis: their use for the characterization of PPAR agonists in the treatment of cardiometabolic disorders
Catherine Fievet, Jean-Charles Fruchart, Bart Staels
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 8, 2008
Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men
Elena Rigamonti, Giulia Chinetti-Gbaguidi, Bart Staels
Trends in Endocrinology and Metabolism: TEM
|
August 12, 2022
Immune-metabolic interactions in homeostasis and the progression to NASH
Joanne A Hoogerland, Bart Staels, David Dombrowicz
Atherosclerosis
|
November 25, 2024
Liver metabolism in human MASLD: A review of recent advancements using human tissue metabolomics
Emily Flam, Joel T Haas, Bart Staels
Nature Reviews. Cardiology
|
November 5, 2014
Macrophage subsets in atherosclerosis
Giulia Chinetti-Gbaguidi, Sophie Colin, Bart Staels
Reviews in Endocrine & Metabolic Disorders
|
October 16, 2004
The Farnesoid X Receptor (FXR) as modulator of bile acid metabolism
Folkert Kuipers, Thierry Claudel, Ekkehard Sturm, et al.
Cellular and Molecular Life Sciences : CMLS
|
December 17, 2014
Nuclear bile acid signaling through the farnesoid X receptor
Claire Mazuy, Audrey Helleboid, Bart Staels, et al.
Nature Reviews. Endocrinology
|
September 17, 2016
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
Barbara Gross, Michal Pawlak, Philippe Lefebvre, et al.
Journal of Lipid Research
|
May 3, 2012
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
Geoffrey Porez, Janne Prawitt, Barbara Gross, et al.
Page
of 64
Search research articles
Search
Showing results (81-90 of 638) with videos related to
Sort By:
Page
of 64
Annual Review of Physiology
|
December 16, 2015
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
Joel T Haas, Sven Francque, Bart Staels
Frontiers in Bioscience : a Journal and Virtual Library
|
May 9, 2007
Genetically-engineered animals as research models for atherosclerosis: their use for the characterization of PPAR agonists in the treatment of cardiometabolic disorders
Catherine Fievet, Jean-Charles Fruchart, Bart Staels
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 8, 2008
Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men
Elena Rigamonti, Giulia Chinetti-Gbaguidi, Bart Staels
Trends in Endocrinology and Metabolism: TEM
|
August 12, 2022
Immune-metabolic interactions in homeostasis and the progression to NASH
Joanne A Hoogerland, Bart Staels, David Dombrowicz
Atherosclerosis
|
November 25, 2024
Liver metabolism in human MASLD: A review of recent advancements using human tissue metabolomics
Emily Flam, Joel T Haas, Bart Staels
Nature Reviews. Cardiology
|
November 5, 2014
Macrophage subsets in atherosclerosis
Giulia Chinetti-Gbaguidi, Sophie Colin, Bart Staels
Reviews in Endocrine & Metabolic Disorders
|
October 16, 2004
The Farnesoid X Receptor (FXR) as modulator of bile acid metabolism
Folkert Kuipers, Thierry Claudel, Ekkehard Sturm, et al.
Cellular and Molecular Life Sciences : CMLS
|
December 17, 2014
Nuclear bile acid signaling through the farnesoid X receptor
Claire Mazuy, Audrey Helleboid, Bart Staels, et al.
Nature Reviews. Endocrinology
|
September 17, 2016
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
Barbara Gross, Michal Pawlak, Philippe Lefebvre, et al.
Journal of Lipid Research
|
May 3, 2012
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
Geoffrey Porez, Janne Prawitt, Barbara Gross, et al.
Page
of 64